Mike Matson
Stock Analyst at Needham
(3.39)
# 980
Out of 5,055 analysts
553
Total ratings
46.71%
Success rate
3.92%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterates: Buy | $448 | $360.13 | +24.40% | 10 | Nov 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.07 | +180.37% | 22 | Nov 13, 2025 | |
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $4.25 → $9 | $6.70 | +34.33% | 2 | Nov 11, 2025 | |
| HAE Haemonetics | Maintains: Buy | $68 → $78 | $74.32 | +4.95% | 15 | Nov 7, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $58 | $45.12 | +28.55% | 20 | Nov 7, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $48 → $70 | $65.84 | +6.32% | 4 | Nov 6, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $10 | $7.48 | +33.69% | 21 | Nov 5, 2025 | |
| VCYT Veracyte | Maintains: Buy | $41 → $44 | $39.28 | +12.02% | 18 | Nov 5, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $85.79 | +25.89% | 31 | Oct 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $42 → $26 | $16.32 | +59.31% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $326 | $278.51 | +17.05% | 12 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $148 | $113.40 | +30.51% | 13 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $74.14 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $121 | $101.76 | +18.91% | 34 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.91 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $53.64 | +19.31% | 27 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $14 | $10.22 | +36.99% | 27 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $96.28 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $28.30 | +73.14% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $33.12 | +35.87% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $41.63 | +46.53% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.71 | +78.84% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $42.83 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $147.03 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $134.52 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $257.01 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $103.86 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $88.64 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $244.71 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $17.92 | +134.38% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $83.64 | -10.33% | 1 | Feb 18, 2021 |
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $448
Current: $360.13
Upside: +24.40%
Lucid Diagnostics
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Insight Molecular Diagnostics
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $6.70
Upside: +34.33%
Haemonetics
Nov 7, 2025
Maintains: Buy
Price Target: $68 → $78
Current: $74.32
Upside: +4.95%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $58
Current: $45.12
Upside: +28.55%
Establishment Labs Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $48 → $70
Current: $65.84
Upside: +6.32%
Personalis
Nov 5, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $7.48
Upside: +33.69%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $41 → $44
Current: $39.28
Upside: +12.02%
Merit Medical Systems
Oct 31, 2025
Reiterates: Buy
Price Target: $108
Current: $85.79
Upside: +25.89%
OrthoPediatrics
Oct 29, 2025
Maintains: Buy
Price Target: $42 → $26
Current: $16.32
Upside: +59.31%
Oct 27, 2025
Reiterates: Buy
Price Target: $326
Current: $278.51
Upside: +17.05%
Oct 23, 2025
Upgrades: Buy
Price Target: $148
Current: $113.40
Upside: +30.51%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $74.14
Upside: -
Oct 17, 2025
Reiterates: Buy
Price Target: $121
Current: $101.76
Upside: +18.91%
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.91
Upside: -
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $53.64
Upside: +19.31%
Aug 29, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $10.22
Upside: +36.99%
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $96.28
Upside: -
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $28.30
Upside: +73.14%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $33.12
Upside: +35.87%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $41.63
Upside: +46.53%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.71
Upside: +78.84%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $42.83
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $147.03
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $134.52
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $257.01
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $103.86
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $88.64
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $244.71
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $17.92
Upside: +134.38%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $83.64
Upside: -10.33%